nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel, bedside, etiology specific prognostic model (Peds-HAV) in hepatitis A induced pediatric acute liver failure
|
Lal, Bikrant Bihari |
|
|
14 |
4 |
p. 483-490 |
artikel |
2 |
Antioxidant therapy on ischemic hepatitis: here we are and where do we go?
|
Maruyama, Hitoshi |
|
|
14 |
4 |
p. 456-459 |
artikel |
3 |
BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?
|
Moghe, Akshata |
|
|
14 |
4 |
p. 460-462 |
artikel |
4 |
Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division
|
Caldez, Matias J. |
|
|
14 |
4 |
p. 463-474 |
artikel |
5 |
Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China
|
Qi, Xiaolong |
|
|
14 |
4 |
p. 478-482 |
artikel |
6 |
Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations
|
, |
|
|
14 |
4 |
p. 415-428 |
artikel |
7 |
Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI
|
Byun, Jieun |
|
|
14 |
4 |
p. 534-543 |
artikel |
8 |
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
|
Fang, Chihua |
|
|
14 |
4 |
p. 437-453 |
artikel |
9 |
Distribution and clinical relevance of phospholipids in hepatocellular carcinoma
|
Liu, Zhirong |
|
|
14 |
4 |
p. 544-555 |
artikel |
10 |
Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population
|
Sayiner, Mehmet |
|
|
14 |
4 |
p. 556-566 |
artikel |
11 |
"Fast, faster, and fastest: science on the run during COVID-19 drama"—"do not forget the liver"
|
Sarin, S. K. |
|
|
14 |
4 |
p. 454-455 |
artikel |
12 |
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model
|
Kong, Fan-En |
|
|
14 |
4 |
p. 521-533 |
artikel |
13 |
Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients
|
Sou, Fai-Meng |
|
|
14 |
4 |
p. 513-520 |
artikel |
14 |
Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI)
|
Saigal, Sanjiv |
|
|
14 |
4 |
p. 429-431 |
artikel |
15 |
Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer
|
Liu, Xiaoli |
|
|
14 |
4 |
p. 567-576 |
artikel |
16 |
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
|
Liu, Hongling |
|
|
14 |
4 |
p. 432-436 |
artikel |
17 |
Models for acute on chronic liver failure development and mortality in a veterans affairs cohort
|
Xiao, Karen Y. |
|
|
14 |
4 |
p. 587-596 |
artikel |
18 |
Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients
|
Yang, Zhongyuan |
|
|
14 |
4 |
p. 491-502 |
artikel |
19 |
SARS-Cov-2 (human) and COVID-19: Primer 2020
|
Ramakrishna, Gayatri |
|
|
14 |
4 |
p. 475-477 |
artikel |
20 |
The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis
|
Zhuge, Shurui |
|
|
14 |
4 |
p. 503-512 |
artikel |
21 |
Utility of N-acetylcysteine in ischemic hepatitis in cirrhotics with acute variceal bleed: a randomized controlled trial
|
Maiwall, Rakhi |
|
|
14 |
4 |
p. 577-586 |
artikel |
22 |
Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients
|
Bihari, Chhagan |
|
|
14 |
4 |
p. 597-608 |
artikel |